| Dr Jennifer Marie Serrano, MD | |
|
Hospital Oncologico, Rio Piedra, PR 00924 | |
| (787) 763-4149 | |
| Not Available |
| Full Name | Dr Jennifer Marie Serrano |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Medical |
| Location | Hospital Oncologico, Rio Piedra, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417389537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 015318-I (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Marie Serrano, MD Hc 8 Box 24678, Aguadilla, PR 00603-9650 Ph: (787) 546-0212 | Dr Jennifer Marie Serrano, MD Hospital Oncologico, Rio Piedra, PR 00924 Ph: (787) 763-4149 |
News Archive
A study conducted at Copenhagen University Hospital showed that treatment of rheumatoid arthritis (RA) with disease modifying antirheumatic drugs (DMARDs), glucocorticoids, biologic agents, or a combination of agents significantly reduced radiographic evidence of joint destruction, with a relative effect of 48%-72% as compared with placebo.
Cannabinoids contain anti-inflammatory properties that could make them useful in the treatment of a wide-range of skin diseases, according to researchers at the University of Colorado Anschutz Medical Campus.
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.
The Learning Lab of Brentwood will present a free seminar, Tips for Parenting ADHD Kids, on Thursday February 25 from 12:00-1:30 PM at the Community Services Building in Franklin. Dr. David Elkins, Clinical Psychologist and Supervising Psychologist of the Assessment Center at The Learning Lab of Brentwood, will lead the seminar.
› Verified 2 days ago